These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 34720027

  • 1. Immune thrombocytopenia.
    Bussel J, Cooper N, Boccia R, Zaja F, Newland A.
    Expert Rev Hematol; 2021 Nov; 14(11):1013-1025. PubMed ID: 34720027
    [Abstract] [Full Text] [Related]

  • 2. ITP and international guidelines: what do we know, what do we need?
    Rodeghiero F, Ruggeri M.
    Presse Med; 2014 Apr; 43(4 Pt 2):e61-7. PubMed ID: 24656296
    [Abstract] [Full Text] [Related]

  • 3. Current approaches for the diagnosis and management of immune thrombocytopenia.
    Gafter-Gvili A.
    Eur J Intern Med; 2023 Feb; 108():18-24. PubMed ID: 36424271
    [Abstract] [Full Text] [Related]

  • 4. Current and emerging treatments for immune thrombocytopenia.
    Dou X, Yang R.
    Expert Rev Hematol; 2019 Sep; 12(9):723-732. PubMed ID: 31237783
    [Abstract] [Full Text] [Related]

  • 5. [Diagnostic approach and treatment of immune thrombocytopenia in adults].
    Kolonić SO, Patekar MB, Milunović V.
    Acta Med Croatica; 2013 Mar; 67(1):3-11. PubMed ID: 24279250
    [Abstract] [Full Text] [Related]

  • 6. Thrombopoietin Receptor Agonists and Other Second-Line Therapies for Immune Thrombocytopenia: A Narrative Review With a Focus on Drug Access in Canada.
    Britto J, Holbrook A, Sun H, Cserti-Gazdewich C, Prokopchuk-Gauk O, Hsia C, Khamisa K, Yenson PR, Sholzberg M, Olney HJ, Shivakumar S, Jones D, Merkeley H, Costello J, Jamula E, Arnold DM.
    Clin Invest Med; 2024 Mar 01; 47(1):13-22. PubMed ID: 38546381
    [Abstract] [Full Text] [Related]

  • 7. Markers of refractory primary immune thrombocytopenia.
    Moulis G, Garabet L.
    Br J Haematol; 2023 Oct 01; 203(1):112-118. PubMed ID: 38019080
    [Abstract] [Full Text] [Related]

  • 8. Refractory primary immune thrombocytopenia (ITP): current clinical challenges and therapeutic perspectives.
    Vianelli N, Auteri G, Buccisano F, Carrai V, Baldacci E, Clissa C, Bartoletti D, Giuffrida G, Magro D, Rivolti E, Esposito D, Podda GM, Palandri F.
    Ann Hematol; 2022 May 01; 101(5):963-978. PubMed ID: 35201417
    [Abstract] [Full Text] [Related]

  • 9. Cost-effectiveness of adding rituximab to splenectomy and romiplostim for treating steroid-resistant idiopathic thrombocytopenic purpura in adults.
    Kikuchi K, Miyakawa Y, Ikeda S, Sato Y, Takebayashi T.
    BMC Health Serv Res; 2015 Jan 22; 15():2. PubMed ID: 25609557
    [Abstract] [Full Text] [Related]

  • 10. Current therapeutic strategies and perspectives in refractory ITP: What have we learned recently?
    Lv Y, Shi H, Liu H, Zhou L.
    Front Immunol; 2022 Jan 22; 13():953716. PubMed ID: 36003388
    [Abstract] [Full Text] [Related]

  • 11. Romiplostim in adults with newly diagnosed or persistent immune thrombocytopenia.
    Lozano ML, Godeau B, Grainger J, Matzdorff A, Rodeghiero F, Hippenmeyer J, Kuter DJ.
    Expert Rev Hematol; 2020 Dec 22; 13(12):1319-1332. PubMed ID: 33249935
    [Abstract] [Full Text] [Related]

  • 12. Childhood immune thrombocytopenia: role of rituximab, recombinant thrombopoietin, and other new therapeutics.
    Journeycake JM.
    Hematology Am Soc Hematol Educ Program; 2012 Dec 22; 2012():444-9. PubMed ID: 23233617
    [Abstract] [Full Text] [Related]

  • 13. Updated guidelines for immune thrombocytopenic purpura: Expanded management options.
    DeSouza S, Angelini D.
    Cleve Clin J Med; 2021 Dec 02; 88(12):664-668. PubMed ID: 34857604
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of ITP].
    Yokoyama K.
    Rinsho Ketsueki; 2021 Dec 02; 62(8):1229-1235. PubMed ID: 34497211
    [Abstract] [Full Text] [Related]

  • 15. Consensus Paper-ICIS Expert Meeting Basel 2009 treatment milestones in immune thrombocytopenia.
    Tamary H, Roganovic J, Chitlur M, Nugent DJ.
    Ann Hematol; 2010 Jul 02; 89 Suppl 1(Suppl 1):5-10. PubMed ID: 20358200
    [Abstract] [Full Text] [Related]

  • 16. Management of primary immune thrombocytopenia, 2012: a survey of oklahoma hematologists-oncologists.
    Lu KH, George JN, Vesely SK, Terrell DR.
    Am J Med Sci; 2014 Mar 02; 347(3):190-4. PubMed ID: 23462246
    [Abstract] [Full Text] [Related]

  • 17. Immune Thrombocytopenia in Children: Consensus and Controversies.
    Singh G, Bansal D, Wright NAM.
    Indian J Pediatr; 2020 Feb 02; 87(2):150-157. PubMed ID: 31927692
    [Abstract] [Full Text] [Related]

  • 18. Treatment of immune thrombocytopenic purpura in children : current concepts.
    Shad AT, Gonzalez CE, Sandler SG.
    Paediatr Drugs; 2005 Feb 02; 7(5):325-36. PubMed ID: 16220997
    [Abstract] [Full Text] [Related]

  • 19. Primary immune thrombocytopenia in adults: Belgian recommendations for diagnosis and treatment anno 2021 made by the Belgian Hematology Society.
    Janssens A, Selleslag D, Depaus J, Beguin Y, Lambert C.
    Acta Clin Belg; 2022 Apr 02; 77(2):470-483. PubMed ID: 33635747
    [Abstract] [Full Text] [Related]

  • 20. [Diagnosis and treatment of immune thrombocytopenia].
    Červinek L.
    Vnitr Lek; 2018 Apr 02; 64(5):526-529. PubMed ID: 30193522
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.